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Fgf8 encodes a key signaling factor, and its precise
regulation is essential for embryo patterning. Here,
we identified the regulatory modules that control
Fgf8 expression during mammalian embryogenesis.
These enhancers are interspersed with unrelated
genes along a large region of 220 kb; yet they act
on Fgf8 only. Intriguingly, this region also contains
additional genuine enhancer activities that are not
transformed into gene expression. Using genomic
engineering strategies, we showed that these
multiple and distinct regulatory modules act as a
coherent unit and influence genes depending on their
position rather than on their promoter sequence.
These findings highlight how the structure of a locus
regulates the autonomous intrinsic activities of the
regulatory elements it contains and contributes to
their tissue and target specificities. We discuss the
implications of such regulatory systems regarding
the evolution of gene expression and the impact of
human genomic structural variations.
INTRODUCTION
Genes contributing to embryonic development are frequently
involved in multiple processes. This pleiotropy is associated
with elaborated gene expression profiles established by special-
ized cis-regulatory modules, each one dedicated to a subset of
the overall expression pattern. In vertebrates, these regulatory
sequences can be remarkably far from the promoter region of
their target genes (Carvajal et al., 2001; Lettice et al., 2003; Spitz
et al., 2003; Zuniga et al., 2004; Kleinjan et al., 2006). Large-scale
screens for sequences with regulatory activities revealed many
enhancers far from genes (Pennacchio et al., 2006; Visel et al.,
2009; Sanyal et al., 2012; Shen et al., 2012), implying further
that long-range regulatory elements exert a prevalent influence
on gene expression. In several instances, remote enhancers
have been shown to act not only on their biologically relevant
targets, but as well on neighboring ‘‘bystander’’ genes (Spitz
et al., 2003; Cajiao et al., 2004; Zuniga et al., 2004), suggesting
that many enhancers may have no intrinsic target specificity.
However, in many other loci, adjacent genes appear to be regu-
lated independently, implying that regulatory mechanisms must530 Developmental Cell 24, 530–542, March 11, 2013 ª2013 Elsevierexist that ensure specificity of functional long-range enhancer-
promoter interactions.
Studies of genes regulated by long-range enhancers have
been instrumental in understanding the mechanisms that influ-
ence enhancer-promoter interactions. Some enhancers prefer-
entially interact with promoters with specific elements, such as
either TATA boxes or downstream promoter elements (DPEs)
(Ohtsuki et al., 1998; Butler and Kadonaga, 2001). Other
promoter-proximal sequences acting as ‘‘tethering elements’’
may help securing interactions with specific enhancers (Calhoun
et al., 2002). Insulator elements with enhancer-blocking activity
can also prevent ectopic interactions between enhancers and
neighboring genes (Chung et al., 1993; Tanimoto et al., 1999;
Murrell et al., 2004). These effects have been proposed to be
mediated by protein complexes comprising CCCTC-binding
factor (CTCF) and cohesins, which can promote formation of
large chromatin loops to bring closer or keep separated
promoters and remote regulatory elements (reviewed in Phillips
and Corces, 2009; Dorsett, 2011). It is noteworthy that these
models are based on detailed and functional studies that have
been carried out on a very small number of loci, often with pecu-
liar structural characteristics: Hox and b-globin multigenic
clusters (Palstra et al., 2008; Spitz and Duboule, 2008), imprinted
regions (Edwards and Ferguson-Smith, 2007), or large gene
deserts (Kokubu et al., 2009). Knowing how enhancer activities
are conveyed to their target genes in more typical loci should
provide additional important insights into the underlying
mechanisms.
Fibroblast growth factor 8 (Fgf8) is expressed during embryo-
genesis in highly restricted domains from where it directs the
formation, growth, and patterning of many organs and struc-
tures, including brain, craniofacial skeleton, limbs, and kidneys
among many others (Crossley and Martin, 1995; Martinez
et al., 1999; Moon and Capecchi, 2000; Macatee et al., 2003;
Grieshammer et al., 2005). Many of the effects driven by Fgf8
are dose-dependent (Jaskoll et al., 2004; Storm et al., 2006),
implying that not only its spatial distribution but also its expres-
sion levels have to be tightly controlled during embryogenesis.
Yet, only a handful of potential Fgf8 cis-regulatory elements
have been identified so far (Hu et al., 2004; Beermann et al.,
2006; Komisarczuk et al., 2009). In contrast to other develop-
mental genes with similarly complex expression patterns, Fgf8
lies in a relatively gene-dense region (Figure 1). This 0.6 Mb
interval contains seven other protein-coding genes: two tran-
scription factors (Tlx1, Lbx1) involved in spleen and limb muscle
development, respectively (Roberts et al., 1994; Gross et al.,Inc.
Figure 1. Structure and Expression of the TLX1-NPM3 Interval
(A) Expression patterns detected by in situ hybridization in E10.5 mouse embryos. Arrows indicate specific expression domains of Lbx1 and Fgf8. AER, apical
ectodermal ridge; BA, first branchial arch ectoderm; CP, forebrain commissural plate; MHB, midbrain-hindbrain boundary; MY, myoblasts; NE, nasal pit
epithelium; SO, somites; TB, tail bud. See Figure S1 for qPCR data.
(B) Organization of the 600 kb-large locus extending from TLX1 to NPM3. Gene bodies are depicted as gray bars, with black ones representing
exons. Centromeric (CEN) and telomeric (TEL) ends and the scale are indicated. A gray square bracket indicates the centromeric end of the BAC used in
Beermann et al. (2006).
(C) Enhancer activity of individual CNEs from the BTRC-FGF8 interval. Genes are shown as gray rectangles, blue ovals depict CNEs with enhancer activity, and
white ovals show tested CNEs that did not show any reproducible expression pattern. CNEs 81 and 83 (light blue) were described previously (Beermann et al.,
2006). For each enhancer element, a picture of a representative embryo is shown.
See also Tables S1 and S2, and Figures 2 and S2 for additional information.
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keyama et al., 1999; Sidow et al., 1999), a DNA polymerase
(Poll) (Bertocci et al., 2002), a member of the nucleoplasmin/
nucleophosmin family of nuclear chaperones (Npm3) (MacArthur
and Shackleford, 1997), and an uncharacterized protein (Dpcd)
(Zariwala et al., 2004). Interestingly, this neighborhood hasDevelobeen largely conserved during evolution (Wotton et al., 2008),
raising the possibility that regulatory elements contributing to
Fgf8 expression may be localized at a distance, intertwined
with the flanking genes. Thus, this region provides an ideal
system to study the mechanisms of enhancer-to-gene
specificity.pmental Cell 24, 530–542, March 11, 2013 ª2013 Elsevier Inc. 531
Figure 2. Multiple CNEs Are Enhancers in
the MHB and the Limb AER
Schematic representation of the region, with
genes as gray or black boxes and CNEs as ovals
(blue, enhancers in theMHB; orange, enhancers in
the AER; expression domains indicated on the
schematic E10.5 embryo on the right). Close-up
views of representative E10.5 transgenic embryos
show the corresponding enhancer activities in the
MHB (upper panel) or AER (lower panel).
See also Figure S2 and Table S2.
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ture of this region. With a variety of transgenic approaches and
targeted rearrangements of the endogenous locus, we show
that this region behaves as an integrated unit, a holo-enhancer:
the internal organization of this intricate 200 kb interval has in
itself an important role in integrating and filtering the activities
of themultiple regulatorymodules present within into a restricted
tissue- and gene-specific output. We discuss the differences of
this regulatory system compared to previously proposedmodels
and how its characteristics can contribute to evolution of gene
expression and account for the phenotypic consequences of
genomic structural variants found in humans.
RESULTS
The Genes Flanking Fgf8 Are Independently Regulated
We investigated the expression patterns of the different genes
present next to Fgf8 in embryonic stage (E) 10.5mouse embryos.
Although whole-mount in situ hybridization revealed the highly
patterned and restricted expression of Fgf8 in these embryos,
its neighbors showed rather ubiquitous signals (Figure 1A), and
we detected their expression in all tissues tested by RT-qPCR
(Figure S1 available online). This basal, ubiquitous expression
suggested that these genes were mostly unresponsive to the
cis-regulatory elements that control Fgf8 expression.
Comprehensive Identification of Enhancers in the
Lbx1-Fgf8 Interval
Previous studies showed that a bacterial artificial chromosome
(BAC) extending from 55 kb centromeric to 120 kb telomeric to
the mouse Fgf8 gene failed to fully rescue the multiple defects
caused by a mutation of Fgf8 (Beermann et al., 2006). This sug-
gested that sequences lying elsewhere were required to drive
Fgf8, notably in the limbs and cranio-facial region. As sequence
conservation is usually a good predictor of developmental
enhancers, we considered noncoding evolutionary conserved
elements (length > 200 bp, PhastCons score > 500) in the
Lbx1-Fgf8 region (see Table S1 for details). We found that
BACs centromeric to Fgf8 recapitulated its expression pattern
in E10.5 embryos (see below), and therefore focused on this
200 kb region. We tested 48 elements for enhancer activity, rep-
resenting collectively more than 20% of the length of the region,
including all the nongenic elements conserved among mammals
found between the 30end of Btrc and Fgf8. Each element was
cloned upstream of a LacZ reporter gene driven by a fragment
of the human b-globin promoter region (37 to +12) (Yee and
Rigby, 1993): this minimal promoter is not active by itself but532 Developmental Cell 24, 530–542, March 11, 2013 ª2013 Elsevierhas been shown to faithfully report the activity of a large variety
of developmental enhancers (Jeong et al., 2006; Gonzalez
et al., 2007) and can be activated in most tissues and embryonic
structures (Ruf et al., 2011).
We found that a majority of these elements conferred repro-
ducible and specific expression patterns to the reporter gene
in transgenic E10.5 embryos (Figures 1, 2, and S2; Table S2).
Several of these patterns overlapped with known Fgf8 expres-
sion domains suggesting that the corresponding enhancers
may contribute to Fgf8 expression. The majority of these
enhancers were active in one or two domains only, revealing
the extreme modular nature of Fgf8 regulation. Collectively,
these enhancers cover most of the known Fgf8 domains of
expression, with the notable exception of the ectoderm of the
branchial arches. Available chromatin immunoprecipitation
(ChIP) data for enhancer-associated marks (p300, H3K27ac)
performed on embryos at comparable stages (Visel et al.,
2009; Blow et al., 2010; Cotney et al., 2012) correlated relatively
well with our transgenic activities (Table S2). Yet, many of the
enhancers we found were not identified by these ChIP experi-
ments, further suggesting that ChIP profiles for these marks
may not offer a complete representation of the enhancers active
in a given tissue (He et al., 2011), likely due to a reduced power to
detect elements active in only a subset of the cells from the
tissue analyzed.
Interestingly, we found multiple elements with overlapping
activities for almost each Fgf8-expressing region (Figures 2
and S2; Table S2). For example, CE79, like its zebrafish ortholog
(Inoue et al., 2006), drove expression in a narrow region corre-
sponding to the midbrain-hindbrain boundary (MHB). However,
we found two additional MHB enhancers (CE80, proximal to
Fgf8, and CE64, distal and inside an intron of Fbxw4), each of
them driving expression in a broader domain (Figures 2 and
S2). The limb apical ectodermal ridge (AER) was characterized
by an unexpected regulatory complexity, with at least five
distinct enhancers being autonomously active in this domain
(CE58, CE59, CE61, CE66, and CE80).
Distal Elements within Fbxw4 Control Fgf8 Expression
Many of these enhancer elements were found far from Fgf8, in
introns of Fbxw4 or beyond. To determine if these elements
contribute to Fgf8 expression, we engineered the deletion
DEL(P-F4) by in vivo Cre-mediated recombination between
loxP sites targeted to the Poll and Fbxw4 genes (Figure 3A;
Supplemental Experimental Procedures). This deletion com-
prises the Fbxw4, Poll, and Dpcd genes. Fbxw4 and Poll do
not play an essential role during embryogenesis (Sidow et al.,Inc.
Figure 3. Characterization of DEL(P-F4) Animals
(A) The DEL(P-F4) allele was produced by trans-allelic recombination (He´rault et al., 1998) between loxP sites (red triangles) targeted to the Poll and Fbxw4 genes.
Enhancers are shown as indicated in Figures 1 and 2.
(B) Morphological appearance at E12.5 and alizarin-red/Alcian-blue stained skeletons of E18.5 embryos of wild-type (WT) and DEL(P-F4)/Fgf8null genotypes.
(C) Whole-mount in situ hybridization showed loss of expression of Fgf8 in DEL(P-F4)/DEL(P-F8) embryos at E10.5. AER, apical ectodermal ridge; BA, first
branchial arch ectoderm; CP, forebrain commissural plate; MHB, midbrain-hindbrain boundary.
See also Figure S3.
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hydrocephalus and situs inversus in mice (Kobayashi et al.,
2002; Vogel et al., 2010). The DEL(P-F4) deletion also includes
enhancers CE58 to CE71. To look at their role regarding Fgf8
expression, we crossed males heterozygous for DEL(P-F4)
with Fgf8null/+ females. DEL(P-F4)/Fgf8null animals retain func-
tional copies of Fbxw4, Poll, andDpcd (from the Fgf8null chromo-
some) but the functional Fgf8 allele lacks the input provided in cis
by the enhancers located in the deleted region, including four of
the five AER enhancers, the three kidney enhancers and a broad
MHB enhancer. Proximal enhancers (up to 90 kb from the Fgf8
promoter) were not affected, notably the MHB enhancer CE79
and the proximal AER/tail bud enhancer CE80. DEL(P-F4)/
Fgf8null embryos were found alive at stage E18.5, however, not
in Mendelian proportions (50% of the expected number).DeveloThese embryos displayed developmental malformations and
defects in many tissues known to be Fgf8-dependent, including
strong craniofacial defects, kidney agenesis, deletion of
midbrain/cerebellum structures, and absence of olfactory bulbs
(Figures 3B, S3B, and S3C) resembling those described in strong
Fgf8 hypomorphs (Meyers et al., 1998). The aplasia of fore- and
hindlimbs observed in DEL(P-F4)/Fgf8null was similar to the one
obtained upon limb-specific inactivation of Fgf8 (Lewandoski
et al., 2000; Moon and Capecchi, 2000), and more severe than
the one seen in hypomorphic alleles (Meyers et al., 1998).
We next examined embryos at earlier stages. At E9.5–10.5,
compound heterozygous for DEL(P-F4) and Fgf8null or DEL(P-
F8), a larger deletion obtained by recombination between the
loxP sites targeted to Poll and Fgf8 (Lewandoski et al., 2000;
Bertocci et al., 2002), were obtained in Mendelian proportionspmental Cell 24, 530–542, March 11, 2013 ª2013 Elsevier Inc. 533
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F4)/DEL(P-F8) embryos were phenotypically similar: they
showed developmental delay, smaller limbs, and malformed
brains compared to wild-type or heterozygous littermates (Fig-
ure 3C; data not shown). They resembled the phenotypic group
1 in the Fgf8 hypomorph series analyzed by Meyers et al. (1998).
To analyze Fgf8 expression from the DEL(P-F4) allele, we used
compound embryos with the DEL(P-F8) allele, which lacked
sequences used for the Fgf8 in situ probe. We failed to detect
Fgf8 expression in DEL(P-F4)/DEL(P-F8) embryos at E9.5–10.5
by whole-mount in situ hybridization, contrarily to wild-type or
DEL(P-F8)/+ controls (Figures 3C and S3; data not shown).
Importantly, expression was lost in domains for which some of
the proximally located enhancers were still present (e.g., CE79
and CE80 for MHB, CE80 for AER), showing that these proximal
elements were not sufficient to initiate or maintain Fgf8 expres-
sion in their domains of activity. In contrast, the analysis of a
deletion removing 320 kb located between Lbx1 and Poll
(DEL(L-P)) showed that it does not contain critical elements
related to Fgf8 (Figure S3E).
Altogether, this genetic analysis showed that the distal
enhancers we identified within Fbxw4 and around Poll-Dpcd
are allelic to Fgf8 and control important aspects of its tissue-
specific expression in midgestation embryos, whereas elements
centromeric to Poll do not contribute noticeably to Fgf8 expres-
sion at this stage of development.
Enhancer Activity versus Gene Expression
Intriguingly, the transgenic screen of individual modules identi-
fied several additional elements in the region that drove highly
reproducible activities in domains that did not correspond
readily to Fgf8. Some of these likely resulted from the increased
stability of the LacZ reporter gene: for example, the staining in
the posterior somites observed with CE80 (Figures 1C and S2)
was most probably due to residual b-gal proteins in cells coming
from the presomitic mesoderm where short-lived Fgf8 mRNAs
are transcribed (Dubrulle and Pourquie´, 2004). Yet, this explana-
tion cannot account for many other ‘‘ectopic’’ patterns that were
observed with other elements, such as in the forebrain (from
CE63 or CE64), the heart (CE71), or the posterior limb mesen-
chyme (CE63). Interestingly, some elements were acting as
enhancers both in an Fgf8 expression domain and in an ectopic
one, as shown by CE62 (in the optic stalk and in the branchial
arch mesoderm, respectively).
These transgenic assays were performed with a neutral but
heterologous promoter. To test if the ectopic domains corre-
sponded to this artificial juxtaposition, we repeated this trans-
genic assay for CE64 and CE71 with the promoter region of
Fgf8. We cloned the mouse Fgf8 region extending from 721
to +198 (transcriptional start site is +1) and fused the LacZ coding
region at Fgf8 start codon. This fragment included the proximal
region highly conserved in mammals and the entire region
decorated by promoter-associated histone marks in Fgf8-ex-
pressing tissues (Shen et al., 2012). With CE71, we obtained
four independent transgenic embryos, none of them showing
reporter gene activity. This result suggests that the Fgf8
promoter may respond less efficiently to CE71 than the b-globin
promoter, even though the difference (0/4 versus 3/7) is statisti-
cally not very significant. In contrast, CE64-Fgf8::LacZ showed534 Developmental Cell 24, 530–542, March 11, 2013 ª2013 Elseviera broad expression pattern in themidbrain-hindbrain, in the fore-
brain, posterior neural tube, and dorsal ganglia of transgenic
embryos, exactly like CE64-bglob::LacZ (Figure 4A). From this,
we concluded that the promoter of Fgf8 is responsive to at least
some of these ectopic activities when put next to these normally
remote enhancers. Therefore, mechanisms other than promoter
specificity must account for the differences observed between
endogenous gene expression and enhancer activity.
To look at these, we used a large human BAC extending from
POLL to the 30end of FGF8, containing the enhancers CE49 to
CE80 but excluding FGF8 promoter region (Figure 4B). This
BAC reproduces more accurately the endogenous genomic
context and should reveal the collective output produced by
the whole region. We inserted the b-globin minimal promoter-
LacZ reporter gene independently at six different positions
along the BAC and injected each modified and linearized BAC
separately. Each BAC with a given insertion showed very repro-
ducible expression patterns between independent transgenic
embryos: embryos with higher BAC copy numbers showed
moderately stronger LacZ signals, but no additional expression
domains (Figure S4). Strikingly, in this assay, most of the ectopic
expression domains observed with single-element transgenes
were not recapitulated (Figures 4 and S4). For example, in the
BAC assay, the CE62-dependent expression in the eye was
maintained, contrary to the branchial archmesenchymal expres-
sion driven by the same element in the single element assay,
even when the reporter gene was inserted only 4 kb away. The
broad forebrain and mid-hindbrain expression domains associ-
ated with CE63/CE64 and CE54/CE64/CE80, respectively,
were drastically reduced in BAC transgenic embryos, matching
more closely to the restricted expression of Fgf8 in these
domains. The cardiac expression driven by CE71 was only
detected locally, when the reporter gene was inserted 7 kb
away (insertion III), but not 30 or 54 kb away (flanking insertions
II and IV, respectively). Additionally, all BAC transgenes showed
robust expression in the branchial arch ectoderm, even though
we failed to find any compact module with such an activity,
autonomously, in our set of evolutionary conserved noncoding
elements.
Altogether, these experiments showed that the regulatory
output of this genomic interval is very different from the superpo-
sition of the activities of the individual modules that compose it.
In the endogenous context, many intrinsic enhancer activities are
filtered out, independently of promoter sequences. Noteworthy,
the output changed with the position of the reporter gene. The
most centromeric insertions showed expression only in few
domains (branchial arches, forebrain, tail bud, and AER) and
usually with weak intensity. Medial insertions (II and III) were ex-
pressed inmost Fgf8 domains, but with a weakMHB expression,
and they showed additional expression domains, such as the
CE71-dependent heart. Insertions IV and V closer to Fgf8 dis-
played an expression pattern very similar to a Fgf8LacZ
knockin-allele (Ilagan et al., 2006), lacked the ectopic heart
expression seen in III, and had a robust MHB expression, partic-
ularly for insertion V. These graded responses to the different
modules, according to the position of the reporter used to record
them, showed that their activities were not evenly distributed
along the locus, in contrast to the wide distribution of the corre-
sponding enhancers. Suggestively, even in absence of Fgf8Inc.
Figure 4. The Regulatory Output of the Region Is Position Dependent
(A) Transgenic analysis of CE64 activity on the human b-globin minimal promoter (b) or on the mouse Fgf8 promoter region. With both promoters, transgenic
embryos showed the same pattern of LacZ staining (forebrain, midbrain-hindbrain region, posterior neural tube, and dorsal root ganglia).
(B) Transgenic embryos carrying the RP11-958B14 BAC showed different LacZ staining depending on the position of the bglob::LacZ reporter gene (insertions
0 to V). The region covered by the BAC (from the 30end of BTRC to FGF8, excluding its promoter) is boxed. For simplicity, only some of the enhancers are
represented. Their color corresponds to their activity, as shown on the schematized embryo (blue, MHB; green, eye; red, heart; orange, AER; purple, regulatory
potentials detected at short range but never in the context of the BAC transgenes). Colored lines depict the distribution of the corresponding regulatory activities
along the region.
Additional embryos with BAC copy numbers are shown in Figure S4.
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as well the absence of ectopic expression) was obtained at prox-
imity of the normal location of this gene.
Enhancer-to-Gene Specificity Depends on the Structure
of the Locus
We reasoned that this uneven distribution of enhancer activities
along the locus may also contribute to ensure that the remote
enhancers interact preferentially with Fgf8 rather thanwith genes
closer to them. To assess the effects of an altered organization of
the locus, we generated transgenic mouse lines by injection of
a circular chicken BAC CH261-53D13 extending from Btrc to
Mgae5 (Figure 5A). When injected as circular molecules, BACs
are prone to adopt an altered organization, depending on the
internal breakpoint used for integration. In transgenic embryos
carrying CH261-53D13, we detected expression of the chicken
transgenic Fgf8 gene in several Fgf8 domains (MHB, AER, bran-
chial arch ectoderm, forebrain, tail bud), showing that this BAC
contained the corresponding regulatory information (Figure 5B).
Unexpectedly, in two independent lines, we found that the
chicken Fbxw4 gene displayed a robust Fgf8-like expressionDevelopattern, contrasting with the basal widespread expression of
the endogenous gene in murine and chick embryos (Figures 1,
2, 3, 4, and 5A–5C). It showed that Fbxw4 was competent to
respond to Fgf8 enhancers, even in presence of a competing
Fgf8 gene, when the structural organization of the locus or its
context was changed. Interestingly, in these cases, Fbxw4 re-
sponded to the multiple independent modules spread across
the region, like Fgf8, and not only to a subset of them.
If the BAC transgenic experiments suggested strongly that the
organization of the region contributed to enhancer-to-gene
specificity, the exact structure of the integrated BACs cannot
be ascertained. Therefore, we produced a series of specific
chromosomal rearrangements affecting the structure of the
endogenous Poll-Fgf8 locus in a targeted manner. We obtained
a balanced inversion that repositioned the Elovl3 gene at the
place of Fgf8 by in vivo Cre-mediated recombination between
loxP sites inserted in Fgf8 and in the 30end of Pitx3 (Figures 6
and S5). In wild-type embryos, Elovl3 was undetectable by RT-
qPCR (Figure 6B). In embryos heterozygous for the inversion,
we found a low but significant expression of Elovl3 in the limb
buds. This expression was strongly enriched in the distal partpmental Cell 24, 530–542, March 11, 2013 ª2013 Elsevier Inc. 535
Figure 5. Altered Gene Specificity in Reshuffled BAC-Transgenic Embryos
(A) Schematic representation of the chicken BAC CH261-53D13 as a boxed interval in the Btrc-Fgf8-Mgae5 locus.
(B and C) In situ hybridization with chicken Fgf8 and Fbxw4 probes of E10.5 mouse embryos transgenic for a circular-injected BAC (two independent lines
c53D13-A and -E), wild-type controls (WT, E10.5 mouse and stage 24 chick embryos). The chicken mRNA probes did not cross-hybridize with mouse genes, and
revealed that cFbxw4 adopted an Fgf8-like expression in CH261-53D13 transgenic embryos.
(D) Close-up apical view of mutant andWT forelimb buds shows presence/absence of the signal in the AER. AER, apical ectodermal ridge; BA, first branchial arch
ectoderm; CP, forebrain commissural plate; MHB, midbrain-hindbrain boundary; SO, somites; TB, tail bud.
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suggesting that this exchange of position led Elovl3 to respond
to Fgf8 AER enhancers. In these embryos, Btrc, Dpcd, Poll,
and Fbxw4 expression levels were unaffected; Lbx1 showed
only a slight upregulation in the limb (Figure 6B).
We produced two additional configurations, DUP(L-F8) and
DUP(L-F4), corresponding to tandem duplications of the region
between the 30end of Lbx1 and the 30end of Fgf8, and between
the 30end of Lbx1 and the second intron of Fbxw4, respectively
(Figures 6 and S5). These duplications positioned the entire
Lbx1 promoter at the position of Fgf8 or in the intron of Fbxw4.
In both cases, the coding sequence of this copy of Lbx1 was
replaced by GFP, allowing direct monitoring of the activity of
the relocated Lbx1 promoter. We collected E10.5 embryos
heterozygous for one or the other configuration. In DUP(L-F8)
embryos, GFP was expressed in all typical Fgf8 domains,
including forebrain and MHB, branchial arches, AER, and tail
bud (Figure 6C). The smaller duplication, where Lbx1 promoter
is not at the Fgf8 position but in the second intron of Fbxw4,
also led to GFP expression in the AER, however, with a much
weaker intensity. The same reduction was seen in the forebrain
and BA ectoderm, whereas other domains (tail bud, MHB)536 Developmental Cell 24, 530–542, March 11, 2013 ª2013 Elsevierwere hardly visible (Figure 6C). These experiments demon-
strated that Lbx1 promoter can respond to the different Fgf8
enhancers, yet much more efficiently when positioned at the
normal location of Fgf8. Altogether, these data showed that
upon structural reshuffling of the locus the output of the Fgf8-
regulatory region was transferred in a coherent manner with
respect to its tissue-specificity to the gene now located at Fgf8
position.
DISCUSSION
An Intricate Regulatory Landscape
Despite the localization of Fgf8 in a gene-dense region, its regu-
latory domain is not smaller than ones described for other genes
(Carvajal et al., 2001; Jeong et al., 2006; Kleinjan et al., 2006;
Montavon et al., 2011). Indeed, many enhancers that regulate
Fgf8 are more than 90 kb away from its promoter, closer to other
genes, and interspersed with Fbxw4 exons. The large number of
enhancers with overlapping tissue-specific activities is particu-
larly striking, as illustrated by the multiple regulatory elements
active in the limb AER. Importantly, the proximal enhancers are
not sufficient to initiate or maintain Fgf8 expression when theInc.
Figure 6. Genomic Position Exchanges
Lead to Regulatory Reallocations
(A) Schematic representation of different configu-
rations DUP(L-F8), DUP(L-F4), and INV(F8-P3).
The loxP sites used to engineer them are indicated
on the wild-type (WT) locus (red triangles). Genes
are shown as boxes, with Fgf8 in black, Lbx1::GFP
in green, Elovl3 in blue and others in gray.
(B) Gene expression levels in distal and proximal
limbs of WT and INV(F8-P3) heterozygous E10.5
embryos expressed in arbitrary units normalized
to ubiquitously expressed genes (Pgk1 and Tbp).
Values shown are mean ± SEM). Upon inversion,
Elovl3 was upregulated specifically in the distal
AER-enriched limb bud (p < 0.01, unpaired t test),
concomitantly with Fgf8 reduction.
(C) GFP expression in embryos heterozygous for
DUP(L-F8) and DUP(L-F4) reproduced Fgf8-like
patterns (white arrows; AER, apical ectodermal
ridge; BA, first branchial arch ectoderm; CP,
forebrain commissural plate; MHB, midbrain-
hindbrain boundary; NE, nasal pit epithelium; TB,
tail bud). A white asterisk indicates GFP signal
corresponding to endogenous Lbx1 expression in
limb myoblasts.
See also Figure S5.
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elements are not simple redundant ‘‘shadow enhancers’’ that
buffer gene expression against genetic or environmental varia-
tions (Hong et al., 2008; Frankel et al., 2010; Perry et al., 2010).
Integration and Interdependence of RegulatoryModules
This functional interdependence between Fgf8 regulatory
elements in the endogenous context contrasts with their func-
tional autonomy in transgenic assays. However, we noticed
that in single element transgenic assays, the different AERDevelopmental Cell 24, 530–54enhancers were quite sensitive to posi-
tion effects: only half of the insertions
showed expression, and some exhibited
mosaic LacZ staining (Figure S2). In
contrast, BAC transgenes with the full
complement of AER modules showed
robust and very penetrant AER expres-
sion, suggesting some kind of synergy.
Several mechanisms may account for
this interdependence and operational
synergy. Different enhancers may fulfill
distinct roles in the context of highly inter-
connected gene regulatory networks,
and the absence of some of them may
lead to a collapse of networks where
Fgf8 has a central role, such as in the
MHB (reviewed in Sato et al., 2004). In
this tissue, CE64 may initiate early
expression of Fgf8, and CE79 may main-
tain Fgf8 expression in response to Pax2
(Inoue et al., 2008). The AER, in contrast,
is not dramatically affected by the
absence of Fgf8, and the impact ondownstream gene expression is minimal (Lewandoski et al.,
2000): in this case, we suggest that the synergy between the
proximal and distal AER enhancers may reflect direct functional
interactions in cis.
Integration and Filtering: Activity versus Function
Strikingly, this region comprises a surprisingly high number of
elements whose enhancer activities are not obviously related
to endogenous gene expression, in contrast to previous equiva-
lent studies of large regions where most elements could be2, March 11, 2013 ª2013 Elsevier Inc. 537
Figure 7. A Holo-Enhancer Region
The Fgf8 gene-dense region comprises multiple
enhancers (ovals) distributed within introns of the
bystander genes (gray rectangles). Enhancers are
color-coded to match the expression domains
depicted on the mouse embryo outlines.
(A) Although individual enhancers possess large
and diverse intrinsic autonomous activities (upper
embryo), their collective output is not equal to their
superposition: only a subset of these activities is
displayed over distance to endogenous genes and
polarized to the genomic position normally occu-
pied by Fgf8 (lower-right embryo).
(B–G) A network of regulatory interactions
between several modules with overlapping activ-
ities organizes this complex region in a coherent
regulatory unit. Different genomic or cellular situ-
ations are shown. Enhancer status is indicated
(filled, active; stroke-only, inactive) and a halo
represents their range of action. Transcriptionally
active genes are represented with arrows. (B)
In Fgf8-expressing cells (e.g., AER), multiple
modules with overlapping activities synergize to
extent their range of action, either by dynamic
one-to-one interactions (left) or by formation of
a meta-enhancer through coalescence of the
different modules (right). (C) Other modules (red),
active in different cell types, may have only
short-range activities and therefore minimal influ-
ence on the surrounding genes. Gene position
relative to Fgf8 normal position determines the
responsiveness to these regulatory elements. Rearrangements have distinct effects, depending on their nature: ectopic action on a new gene (D and E); loss of
expression (F); and unmasking of a latent regulatory potential (G). These situations can correspond to conditions found in SHFM3 patients.
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2001; Uchikawa et al., 2003; Kleinjan et al., 2006; Gonzalez
et al., 2007). These elements are operational ‘‘enhancers’’ (as
defined by an in vivo transgenic assay) and some harbor chro-
matin marks characteristic of enhancers in vivo: CE71 is bound
by p300 in E11.5 embryonic heart (Blow et al., 2010), and
CE63 is enriched for H3K27Ac in E11.5 limbs (Cotney et al.,
2012). These elements can act on a range of promoters,
including Fgf8, suggesting that promoter-defined local chro-
matin environment may not be sufficient to protect genes from
their influence. Nevertheless, a large part of the activities of the
individual modules appears to be operationally filtered out in
the endogenous context. There is therefore an important gap
between the intrinsic regulatory potential of an enhancer (the
activity it can display when randomly inserted in the genome,
reflecting the properties of its sequence and of the transcription
factors that bind to it) and its regulatory function (its contribution
to gene expression in its normal genomic position) that can be
much more restricted (Figure 7A). The BAC assays suggest
that these intrinsic regulatory potentials are displayed at short
distances: only some of them are active over larger distances
and are therefore able to reach potential target genes. Gene
promoters play only a minor role in this integration/filtering
process, whereas the genomic positions of the potential target
genes seem to be a more critical factor.
Holistic Control of Gene Expression
Interestingly, we noticed that Fgf8 expression domains were
often associated with multiple enhancers, whereas the ectopic538 Developmental Cell 24, 530–542, March 11, 2013 ª2013 Elsevierenhancer activities found in the region were usually represented
by a single module. This observation suggests that cis-interac-
tions between the different modules with overlapping activities
may reinforce the frequency of their association with the target
gene, up to their coalescence with bound transcription factors
into a large enhancing complex over the Fgf8 promoter (Fig-
ure 7B). As shown for the Sonic hedgehog gene, remote
enhancer-promoter interactions may be infrequent and lead to
sporadic gene expression at the cellular level (Amano et al.,
2009; Noordermeer et al., 2011). Multiple AER enhancers can
synergize through direct interactions or simply increase the
chance that the Fgf8 promoter would be in contact with any
one of them, to compensate for the possible paucity of pairwise
interactionsmediated by single remote elements. In contrast, the
ectopic activities associated with single modules may not yield
productive transcription on remote target promoters due to
weak or infrequent interactions.
Interactions between multiple enhancers may lead the region
to adopt a defined structural conformation that could favor regu-
latory interactions between enhancers and specific positions of
the locus instead of with specific promoter sequences. This is
what suggests the uneven distribution of enhancer activities on
the BAC transgenes and the general tropism for the position
normally occupied by Fgf8. Even though it is possible to decon-
struct it into autonomous modules, the whole region seems to
work as a coherent integrated regulatory ensemble, which over-
all activity cannot simply be determined by the addition of its
basal components. The importance of the genomic context in
shaping both the tissue- and the target-specificity of this regionInc.
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interactions between the different active elements, involving
eventually additional interspersed structural elements, will deter-
mine where the regulatory influences are exerted: hence, the
output of the entire region would reside in the relative distribution
of genes and enhancers along the locus (Figure 7).
Additional levels of regulation such as the epigenetic status of
the promoters could further contribute to shape the gene-
specific response to these inputs. Indeed, Fgf8 is often covered
with the repressive mark H3K27me3 in nonexpressing tissues
and cell types (Shen et al., 2012). Yet, the transgenic assay
showed that the Fgf8 promoter region does not carry itself the
information that can lead to its epigenetic repression in all the
tissues in which we detected ectopic regulatory activities.
Furthermore, the BAC assays and the duplications relocating
Lbx1 showed that the filtering process operated on multiple
and diverse promoters, suggesting further that the regulatory
output of the region is mostly promoter-independent. It implies
that keeping promoters away from the elements with intrinsic
ectopic activities is essential to avoid gene misexpression.
Previous studies have highlighted the role of powerful locus-
wide acting regulatory elements such as the b-globin locus
control region (Palstra et al., 2008) or the Hox global control
region and regulatory archipelago (Spitz et al., 2003; Montavon
et al., 2011). These elements may be well adapted to gene-
deserts or extended gene clusters, but they can constitute regu-
latory challenges in intricate regions comprising multiple genes
that need to be regulated independently. One could imagine
that batteries of enhancer-blocker elements and silencers may
in theory achieve the specificity observed in the Fgf8 locus.
But these elements would need to have additional properties
(short range of action, enhancer-specificity) to avoid pleiotropic
effects on the surrounding active genes. Several CTCF binding
sites have been identified along the region (Shen et al., 2012).
However, given their interlaced distribution between the
enhancers and the different target genes, their contribution
would be very different from the strict enhancer-blocker usually
envisioned. As CTCF, cohesin and mediator proteins are ubiqui-
tously expressed, it is unclear how they could organize cell-type-
specific interactions (Hou et al., 2010). The consequences of the
engineered rearrangements at the Fgf8 locus further suggest
that there is no recognition code between pairs of CTCF sites
to direct enhancers toward a specific target gene. Instead,
dynamic interactions between the multiple modules active in
a tissue and target gene(s) may bring transiently specific CTCF
sites in close proximity, enabling eventually CTCF-cohesin
complexes to in turn stabilize these active conformations. In
this way, the system used at the Fgf8 locus may be very appro-
priate for a gene-dense region: the interdependency of the
short range-modules and the resulting positional tropism of
the regulatory region would ensure both specificity and precision
and limit the collateral effects that characterize other systems
(Montavon et al., 2008).
Evolutionary Implications
The extended and interlaced structure of the Fgf8 regulatory
landscapewith other genesmay have acted as a strong pressure
to preserve its synteny. Indeed, the Fbxw4-Fgf8 association has
been maintained in both chordates and hemichordates (Can˜es-Develotro et al., 2007). Interestingly, in teleost fishes, one of the dupli-
cated Fgf8 loci retained the original genomic structure, keeping
Fbxw4 as well as the intragenic and intergenic conserved
elements/enhancers, whereas the other copy lost most of the
ancestral elements. This unequal partition further suggests that
this large regulatory region functions as a whole unit. As noted
previously, the existence of multiple enhancers with overlapping
activities can confer robustness, as proposed for shadow
enhancers. It constitutes a flexible system where modifications
of individual elements can modulate Fgf8 expression and limb
morphologies. Remarkably, the functional interdependence of
the different modules can act as a pressure to maintain such
a situation, favorable for evolutionary experimentation. The
presence of additional regulatory activities embedded in the
holo-enhancer may also facilitate the acquisition of new expres-
sion domains, for example by unmasking a latent activity already
present, without a need for evolving new enhancers. These latent
regulatory potentials may be a by-product of the regulatory code
associated with a role of these modules in a different tissue or
at a later stage. As enhancers seem constrained in keeping
their regulatory syntax (Brown et al., 2007), silencing or filtering
these additional associated activities out may be evolutionary
simpler than evolving a more specific module.
Holo-Enhancers, Human Genomic Disorders,
and Structural Variations
Our findings provide also a conceptual framework to understand
the consequences of genomic changes affecting this region. In
humans, duplications of the region lead to split hand/split foot
malformation type 3 (SHFM3), a condition characterized by limbs
missing the central digits, associated in some patients with
micrognathia and hearing disorders (de Mollerat et al., 2003;
Dimitrov et al., 2010). These duplications disrupt the organization
of the region, whichmay lead tomisexpression of one or multiple
genes; their nature and new ectopic patterns may vary, depend-
ing on the breakpoints, similarly to what we observed with
a GFP-tagged Lbx1 gene in mice carrying corresponding dupli-
cations. Hence, if holo-enhancers build their specific output
from sparse elements with widespread activities by using
genomic structure and distance to filter them, they may be quite
sensitive to structural alterations (Figure 7). The SHFM3-like
condition in Dactylaplasia mice due to insertions of retro-
elements within the holo-enhancer region (Sidow et al., 1999;
Friedli et al., 2008) further emphasizes the sensitivity of this
system toward what could appear as relatively mild genomic
changes. Likewise, structural variations found in humans (Stan-
kiewicz and Lupski, 2010) could lead to phenotypic diversity not
only by altering specific elements, but also by modifying an
underlying organization that controls how multiple regulatory
inputs present within a locus are transformed into specific
gene expression activities.
EXPERIMENTAL PROCEDURES
Transgenic Analyses
Each CNE enhancer candidate was cloned upstream of a LacZ reporter gene
(blac) driven by a b-globin-derivedminimal promoter (detailed in Supplemental
Experimental Procedures). Gel-purified linear fragments were microinjected
into fertilized mouse oocytes and transferred to pseudo-pregnant females
(EMBL Transgenic Service; Cyagen Biosciences Guangzhou). Founderpmental Cell 24, 530–542, March 11, 2013 ª2013 Elsevier Inc. 539
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genotyped by PCR on yolk sack DNA.
Human RP11-958B14 and chicken CH261-53D13 BACswere obtained from
CHORI. RP11-958B14 was targeted with a blac reporter gene by ET-recom-
bineering (see Supplemental Experimental Procedures), except insertion 0,
which was produced by Tn7-mediated transposition (Spitz et al., 2003).
RP11-958B14 derivatives were linearized with PI-SceI, whereas CH261-
53D13 was injected as a circular molecule. Otherwise, BAC DNA were purified
and microinjected as described previously (Zuniga et al., 2004). Transgenic
embryoswere genotyped by PCR. For RP11-958B14, we verified the presence
of 16 specific landmarks using human-specific primers and only embryos
carrying an entire BAC construct were considered for further analysis; most
of these carried from one to two copies of the BAC with few having five or
seven copies (see Supplemental Experimental Procedures for details).
Mouse Strains with Targeted Rearrangements
The inversion INV(F8-P3) was generated by STRING (Spitz et al., 2005), using
strains with loxP sites in the Fgf8 gene (F8) (Meyers et al., 1998), the 30UTR of
Pitx3 (P3) (Zhao et al., 2004), and an Hprt-Cre driver (Tang et al., 2002). Other
alleles were produced by targeted meiotic recombination (TAMERE) (He´rault
et al., 1998), using strains with the following loxP sites: F8 in Fgf8, Lbx1::GFP
(L) (Vasyutina et al., 2005), and Poll (P) (Bertocci et al., 2002). The loxP site in
Fbxw4 (F4) was introduced by homologous recombination in ES cells
(see Supplemental Experimental Procedures). The different strains were
genotyped by PCR.
X-Gal Staining, GFP Imaging, In Situ Hybridizations, and Skeletal
Preparation
b-galactosidase staining and whole-mount in situ hybridization were per-
formed according to standard protocols. In situ probes included mouse and
chicken Fgf8 (Crossley and Martin, 1995; Crossley et al., 1996), murine probes
for Btrc, Poll, Dpcd, Fbxw4, and the probe for chick Fbxw4 were subcloned
from EST clones (IRAKp961-O218, -G216, -I1567, -F0653, and chick EST
441j4, respectively), and mouse Lbx1 and Elovl3 probes were amplified by
PCR (Supplemental Experimental Procedures) from cDNAs from embryonic
tissues, subcloned and sequenced. GFP expression was assessed with a
Leica MZ16F fluorescent stereomicroscope and a Zeiss LSM780 laser-scan-
ning microscope. Skeletons of E18.5 mouse embryos were prepared and
stained with standard Alcian blue/Alizarin red protocols.
Mouse experiments were conducted in accordance with the principles and
guidelines in place at European Molecular Biology Laboratory, as defined and
overseen by its Institutional Animal Care and Use Committee, in accordance
with the European Directive 2010/63/EU.
Quantitative RT-PCR
Total RNA was purified from tissues dissected from E10.5 embryos. Detailed
protocol and primers are listed in the Supplemental Experimental Procedures.
Gene expression was normalized to multiple controls (Actb, Pgk1, and Tbp
genes), using the 7500 software V2.0.5 (Applied Biosystems). Each sample
corresponded to tissues pooled from three to four embryos. Two to three
biological replicates were used for each condition and each measurement
was made in duplicate.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.devcel.2013.01.025.
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